Skip to main content
. 2018 Jul 2;2018:6430701. doi: 10.1155/2018/6430701

Table 3.

Comparison of the adverse events between the EST and EPLBD groups.

EST EPLBD P value
(n = 60) (n = 161)
Pancreatitis 2 (3.3%) 8 (5.0%) 0.73
 Mild 2 7
 Moderate 0 1
 Severe 0 0
Hemorrhage 0 0
Cholangitis 2 (3.3%) 3 (1.9%) 0.62
Perforation 0 0
Overall adverse events 4 (6.7%) 11 (6.8%) 1.00